Suprema Launches BioStation 3


Suprema has launched ‘BioStation 3’, a contactless access control terminal specialized for facial recognition in the post-covid era.

BioStation 3 is a next-generation access control solution created by integrating Suprema’s 20 years of expertise in access control and authentication-related technologies. In addition to facial recognition — the representative contactless authentication method of the post-covid era — various other contactless credential options are offered to enhance user convenience, including QR codes, barcodes, mobile access cards and RFID cards. BioStation 3 features increased usability and a compact, slim body that is reduced in size by 47% compared to Suprema’s predecessor, FaceStation F2, allowing for easy installation on any door, from small offices to enterprise environments.

In addition, Suprema has adopted the advanced AI processor — a Neural Processing Unit (NPU). BioStation 3 is an advanced edge device that can run AI algorithms locally with an embedded NPU to maximize the performance of the AI engine. Accurate authentication is possible even for faces with various types and colors of masks, hairstyles, hats and glasses.

Moreover, as the importance of biometric and personal information protection is increasing, BioStation 3 is certified with ISO/IEC 27001, an international standard that helps organizations manage the security of their information and is designed to comply with GDPR, one of the world’s strictest privacy regulations. One of the initiatives in protecting personal data is ‘Face Template on Mobile’, a first in the industry, which is an authentication method independently developed by Suprema that allows users to store and manage their facial authentication template on their mobile phone without having to store it in the company’s database.

“BioStation 3 is a product that integrates all of Suprema’s innovative technologies so that everyone around the world can conveniently and safely control and manage all kinds of doors in the post-pandemic world,” said Suprema Inc. CEO Hanchul Kim. “With BioStation 3, Suprema will set a new standard in access control and provide a unique customer experience.”


Comments are closed.